Sentence examples for analysis of a prevalence study from inspiring English sources

As this study was based on secondary analysis of a prevalence study [ 20], no evaluation of the statistical power for comparison purposes could be done.

When the Navy SEAL study [ 21] was eliminated from the analysis of creatine prevalence, studies on Rangers and Special Forces soldiers had a SPE = 19% and S95% CI = 16-21 (p = 0.88 for homogeneity).

Pooled analysis of 24 retrospective prevalence studies revealed a higher risk of H. pylori infections among endoscopy personnel, which was statistically significant.

A meta-analysis of 33 prevalence studies involving 1931 T1D cases and 2517 controls confirmed a clinically significant association between enteroviral infections and islet autoimmunity and T1D in humans (Yeung et al., 2011).

In contrast, a recent meta-analysis of HCV prevalence studies reported no significant difference in prevalence between men and women (27).

4 A recent meta-analysis of HIV prevalence studies among female sex workers (FSWs) in low-income and middle-income countries suggested that FSWs including from Europe Georgia, Estonia and Ukrainee)—had higher odds of HIV compared with all women of reproductive age. 5 Evidence also suggests that the size of the female sex working population is correlated with countrywide HIV prevalence.

The primary aim of this review is to examine the association between aggression and genetic syndromes by analysis of prevalence studies.

A meta-analysis of prevalence studies found that the rates of various anxiety disorders in patients with schizophrenia and related psychotic disorders ranged from 10-15% [ 1401].

The World Alzheimer Report 2009 [ 5], which used a meta-analysis of prevalence studies, estimated that globally 35.6 million people aged over 60 (4.7% of that age group) would be living with dementia in 2010, rising to 115.4 million people by 2050.

The HR type HPV-35 was the second most prevalent type (10%) in this study and meta-analysis of worldwide HPV prevalence studies shows low overall prevalence of HPV-35 (≈2%), even in Africa (Clifford et al, 2003b).

In another retrospective analysis of an open-label study, the reported prevalence of gynecomastia or breast discomfort was 6%% in patients when on doses of 25 50 mg/day [ 115].